← back to search

Stefan Offermanns

Institute for New Media · DE
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Receptor Mechanisms and Signaling, Protein Kinase Regulation and GTPase Signaling, Axon Guidance and Neuronal Signaling, and Nitric Oxide and Endothelin Effects.
h-index
107
citations
46,203
works
659
NIH funding
primary concept
email

Recent publications

The reciprocal endothelium-adipose loop fuels cardiometabolic diseases.
2026cited by 0position: contributordoi
International Union of Basic and Clinical Pharmacology xxx: Applying an objective evaluation to the status of Class A orphan G protein-coupled receptors
Pharmacological Reviews 2026cited by 0position: contributordoi
Insulin Resistance: An Update on Biochemical and Pathophysiological Mechanisms and Impact on Various Diseases
iNew Medicine 2026cited by 0position: contributordoi
Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis
Nature Cardiovascular Research 2025cited by 30position: middledoi
Endothelial insulin resistance induced by adrenomedullin mediates obesity-associated diabetes.
2025cited by 29position: contributordoi
PIEZO1 mediates periostin+ myofibroblast activation and pulmonary fibrosis in mice
Journal of Clinical Investigation 2025cited by 27position: middledoi
Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake
Journal of Clinical Investigation 2025cited by 22position: middledoi
Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis.
2025cited by 21position: contributordoi
The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.
2025cited by 20position: contributordoi
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21.
2025cited by 11position: contributordoi
Orphan G protein-coupled receptor GPRC5B controls macrophage function by facilitating prostaglandin E receptor 2 signaling.
2025cited by 9position: contributordoi
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
2025cited by 9position: contributordoi
FFAR4-mediated IL-6 release from islet macrophages promotes insulin secretion and is compromised in type-2 diabetes.
2025cited by 7position: contributordoi
Phosphorylation of endothelial histone H3.3 serine 31 by PKN1 links flow-induced signaling to proatherogenic gene expression.
2025cited by 5position: contributordoi
Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2.
2025cited by 4position: contributordoi
Inclusion of ACKR5 in the systematic nomenclature of atypical chemokine receptors.
2025cited by 3position: contributordoi
Butyrate receptor HCAR2/GPR109A controls imiquimod-induced psoriasis-like skin inflammation.
2025cited by 3position: contributordoi
Nuclear eNOS Interacts With and <i>S</i>-Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function.
2025cited by 2position: contributordoi
The tumor suppressor FAT1 controls YAP/TAZ protein degradation and tumor cell proliferation through E3 ligase MIB2.
2025cited by 1position: contributordoi
Adventitial Fibroblasts Release Interleukin 6 After Vascular Injury and Induce Smooth Muscle Cell Proliferation and Neointima Formation.
2025cited by 1position: contributordoi
Orphan receptor GPR153 facilitates vascular damage responses by modulating cAMP levels, YAP/TAZ signaling, and NF-κB activation.
2025cited by 0position: contributordoi
Author response: Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2
2025cited by 0position: contributordoi
Hydroxycarboxylic acid receptors in GtoPdb v.2025.3
IUPHAR/BPS Guide to Pharmacology CITE 2025cited by 0position: contributordoi
Regulation of Insulin Secretion Through Long‐Chain Fatty Acid Receptors
iNew Medicine 2025cited by 0position: contributordoi
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor.
2024cited by 31position: contributordoi
Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung
Nature Communications 2024cited by 20position: middledoi
Clinically used broad-spectrum antibiotics compromise inflammatory monocyte-dependent antibacterial defense in the lung.
2024cited by 14position: contributordoi
Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling
Arteriosclerosis Thrombosis and Vascular Biology 2024cited by 13position: lastdoi
Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling.
2024cited by 10position: contributordoi
Protein kinase N promotes cardiac fibrosis in heart failure by fibroblast-to-myofibroblast conversion.
2024cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 86 papers (2019–2026)Thomas Worzfeld · Philipps University of Marburg33 papers (2021–2023)Matthew J. Smalley · Cardiff University31 papers (2023–2023)David F. Griffiths · University Hospital of Wales31 papers (2023–2023)Magali Williamson · King's College London31 papers (2023–2023)Neil Trent · Musgrove Park Hospital31 papers (2023–2023)Boris Shorning · Cardiff University31 papers (2023–2023)Nina Wettschureck · Max Planck Institute for Heart and Lung Research18 papers (2013–2025)Nina Wettschureck · German Center for Lung Research10 papers (2021–2025) · 9 papers (2020–2025)Boris Strilić · Johannes Gutenberg University Mainz8 papers (2013–2022)Shengpeng Wang · Zhejiang A & F University8 papers (2015–2025)Haruya Kawase · Nagoya University Hospital7 papers (2023–2025)Julián Albarrán-Juárez · Aarhus University7 papers (2015–2019) · 6 papers (2012–2019)Harmandeep Kaur · Indiana University School of Medicine5 papers (2015–2019)Jingchen Shao · Heinrich Heine University Düsseldorf5 papers (2022–2025)Stefan Günther · Life & Brain (Germany)5 papers (2023–2025)Rémy Bonnavion · Max Planck Institute for Heart and Lung Research5 papers (2021–2025)Cong Tang · Nanjing Medical University5 papers (2012–2017)